• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Corvia Medical

Corvia Medical closes $54M financing to support atrial shunt

June 9, 2022 By Sean Whooley

Corvia Medical announced today that it closed a $54 million equity financing from its existing investor syndicate. Tewksbury, Massachusetts–based Corvia Medical earmarked the funds to support a confirmatory trial to build upon data and learnings from the clinical trial of its Corvia atrial shunt in heart failure patients with preserved (HFpEF) or mildly reduced HFmrEF […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Funding Roundup, News Well, Structural Heart Tagged With: Corvia Medical

Corvia Medical reports encouraging results from trial of atrial shunt

April 1, 2022 By Sean Whooley

Corvia Medical today announced positive data from the global phase III clinical trial of its atrial shunt in heart failure patients. Tewksbury, Massachusetts–based Corvia published analyses from its global, phase III Reduce LAP-HF II randomized trial of heart failure (HF) patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction online in Circulation. According to […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, News Well, Structural Heart Tagged With: Corvia Medical

Corvia Medical’s atrial shunt trial fails primary endpoint

February 2, 2022 By Chris Newmarker

Corvia Medical’s atrial shunt device did not reduce heart failure rates or improve health status in a 626-patient study published on The Lancet’s website. The REDUCE LAP-HF II results appear to be bad news for Tewksbury, Massachusetts-based Corvia — as well as Edwards Lifesciences, which agreed in 2019 to pay $35 million for the rights […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Featured, News Well Tagged With: Corvia Medical

FDA grants breakthrough nod for Corvia’s interatrial shunt

October 9, 2019 By Sean Whooley

Corvia Medical said today that it won FDA breakthrough device designation for its interatrial shunt device for heart failure. The Tewksbury, Mass.-based company’s interatrial shunt is designed to lower blood pressure in the left atrium and lungs by creating a small opening between the left and right atria. It’s the world’s first transcatheter device indicated […]

Filed Under: Cardiac Implants, Food & Drug Administration (FDA) Tagged With: Corvia Medical

Corvia Medical taps PhysIQ for remote monitoring in interatrial shunt study

September 13, 2019 By Sean Whooley

Corvia Medical said it launched a heart failure device trial that will include the collection and analysis of data with PhysIQ’s continuous remote monitoring platform. The Phase III trial is designed to evaluate the efficacy of Tewksbury, Mass.-based Corvia’s interatrial shunt in patients with heart failure. The randomized, controlled, double-blinded study includes plans to provide […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, News Well Tagged With: Corvia Medical

Corvia Medical’s interatrial shunt study meets endpoints

August 27, 2018 By Brad Perriello

Corvia Medical said today that a clinical trial of its Interatrial Shunt Device for treating heart failure met its primary endpoints at one year. Tewksbury, Mass.-based Corvia last November launched the Reduce LAP-HF II clinical trial ahead of a bid for FDA approval. The company’s IASD is designed to lower blood pressure in the left atrium and […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials Tagged With: Corvia Medical

Corvia Medical launches Interatrial Shunt Device heart failure trial

November 14, 2017 By Fink Densford

Update: Corrected from previously mislabeled ‘interarterial’ to ‘interatrial’ shunts Corvia Medical said today it launched the Reduce LAP-HF II clinical trial of its transcatheter Interatrial Shunt Device designed to treat heart failure as it seeks FDA approval of the device. The Tewksbury, Mass.-based company said the 1st patient in the trial was enrolled by Dr. Rami Kahwash […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Regulatory/Compliance Tagged With: Corvia Medical

Corvia Medical touts 1-year data for InterAtrial shunt

November 22, 2016 By Fink Densford

Corvia Medical today released 1-year results from the Reduce LAP-HF clinical trial of its InterAtrial shunt device, touting a good safety profile and sustained device performance. Results from the 64-patient study was presented at the American Heart Association’s 2016 Scientific Sessions. The Tewksbury, Mass.-based company’s IASD is designed to lower blood pressure in the left atrium […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials Tagged With: Corvia Medical

Corvia Medical lands CE Mark for heart shunt

May 12, 2016 By Brad Perriello

Corvia Medical said today that it landed CE Mark approval in the European Union for its InterAtrial Shunt device for treating a type of heart failure. The IASD is designed to lower blood pressure in the left atrium and lungs by creating a small opening between the left and right atria. It’s indicated for diastolic heart […]

Filed Under: Cardiac Implants, Clinical Trials, Regulatory/Compliance Tagged With: Corvia Medical

Corvia Medical wins FDA nod for trial, inks exclusive buyout deal with strategic backer

March 7, 2016 By Brad Perriello

Corvia Medical said today that it won an investigational device exemption from the FDA for a clinical trial of its cardiac implant designed to treat diastolic heart failure and inked a deal with an unnamed strategic investor that includes an exclusive buyout option. Corvia’s transcatheter InterAtrial shunt device is designed to lower blood pressure in the left atrium […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Mergers & Acquisitions Tagged With: Corvia Medical

Corvia Medical raises $34m for heart failure implant

September 22, 2015 By Brad Perriello

Corvia Medical, which is developing a cardiac implant designed to treat diastolic heart failure, yesterday said it raised a $34 million equity round. Tewksbury, Mass.-based Corvia said in a regulatory filing that 9 unnamed investors participated in the round, which logged its 1st sale in June 2014. The company, formerly known as DC Devices, closed a $10.7 million funding […]

Filed Under: Cardiac Implants, Catheters, Funding Roundup Tagged With: Corvia Medical

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS